McKesson Corporation (MCK) fundamentals: P/E, valuation, undervalued?
McKesson Corporation · Health Care · ref. ETF XLV · price $890.51
In short — McKesson Corporation trades at 24.0× earnings (P/E), 17.6× forward, with a net margin of 1.1 % and revenue growth of +8 %. Read: Average P/E (P/E 24 (near the ~20-25 average)).
Is McKesson Corporation stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$890.51+30.8% over range
Aug 28, 25low $681.02 · high $995.69Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
80% recommend buying · 10 analysts
Valuation : Average P/E — P/E 24 (near the ~20-25 average)
Valuation
24.0
P/E (price/earnings)
17.6
Forward P/E
—
PEG
—
Price/book (P/B)
$103.8B
Market cap
37.05
EPS
Profitability & growth
1.1 %
Net margin
+8 %
Revenue growth
-18 %
Earnings growth
$11.8B
Total debt
McKesson Corporation income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2023 | $276.7B | $3.6B | 1.3 % |
| 2024 | $309.0B | $3.0B | 1.0 % |
| 2025 | $359.1B | $3.3B | 0.9 % |
| 2026 | $403.4B | $4.8B | 1.2 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is McKesson Corporation's P/E and is the stock undervalued? What's a good P/E?
McKesson Corporation's P/E is 24.0 (forward 17.6). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Average P/E".
Is McKesson Corporation profitable?
McKesson Corporation has a net margin of 1.1 % (EPS 37.05). The company is profitable.
Is MCK stock expensive?
Our read: "Average P/E" — P/E 24 (near the ~20-25 average). Cross-check with growth and sector.
💬 A question about McKesson Corporation? The JPI assistant answers using our backtest data.
Keep exploring McKesson Corporation